News
DoP releases draft policy to catalyse R&D and innovation in pharma-MedTech sector
The draft policy aims to encourage R&D in Pharma-MedTech sector, and promoting innovation for India to become a leader in drug discovery and innovative medical devices through incubating an entrepreneurial environment. The department has invited comments from the stakeholders by November 6, 2021.
Union Minister of Health and Family Welfare, GoI, launches first commercial batch of COVAXIN® manufactured in Ankleshwar, Gujarat
Bharat Biotech, a global leader in vaccine development and innovation, today announced the commercial launch of the first batch of COVAXIN® from its Chiron Behring Vaccines facility in Ankleshwar, Gujarat. Hon’ble Union Health Minister of Health and Family Welfare Shri. Mansukh Mandaviya inaugurated the COVAXIN® batches.
IVI and Bharat Biotech launch Global Chikungunya Vaccine Phase II/III trial in Costa Rica
IVI is leading the Global Chikungunya vaccine Clinical Development Program (GCCDP) consortium in partnership with Bharat Biotech and with support from the Coalition for Epidemic Preparedness Innovations (CEPI) and Ind-CEPI.
Indian Immunologicals hands over first lot of Covaxin drug substance to Bharat Biotech
To augment the capacity of covid-19 vaccine production in the country, the central government requested that Indian Immunologicals Ltd (IIL) and Bharat Biotech International Limited (BBIL) join hands in April 2021.
Archives
SMART BIO AWARDS 2021
